subject

catch
explosion
breaking
newsbio


matrix
scientific
group


inc

symbo
|


bmxg


pkindustry


biotechnoiogy
;
stem
ceil
technoiogies

current
price




85shares
out




8


o
millionest


fioat


2


5
millionprojected
valuation


3


50
per
sharebio


matrix
scientific


banking
stem
cell
research

bmxg
stem
ceil


oriented
biotechnoiogy
r


d
firm


openingtwo
innovative
adultstem
cell
cryogenic
banks


cryobanks
wiil
providenear


term
revenue
stream
whiie
bmxg
develops
new
innovative
stemcell
technoiogies
products

stem
ceil
revolution

breakthroughs
late
1990
'


stem
ce
|
|
research
oneof
exciting
developments
biotechnoiogy


promising
aid
inthe
treatment
cure
degenerative
chronic
diseases


includingleukemia


cancer


diabetes


scientists
stem
ce
|
|
thefuture
medical
science


offering
potential
cures
host
ofdiseasesand
degenerative
conditions


market
research
firm


visiongain
hasestimated
stem
cel
|
products
wil
|
account
over
lo
billion
inannualsales
2
ol
3


phenomena
|
growth
industry
existonly
few
years
ago


one
significant


near


termcommerciaiization
opportunities
research
useof
stemceils
bone
marrow
transpiant


increasingly


individuals
arechoosingto
store
stem
cells
cryogenic
banks
future
use
infighting
disease


new
industry
cord
blood
banks
speciaiizedtranspiant
clinics
already
risen
meet
demand


andsuccessfu
|technoiogy
couid
meet
annua
|
need
over
150


ooo
operations

viacellhas
estimated
market
cord
biood
preservation
over
1


2billion


2
bi
|
|
ion
globa
|
|
y

recent
active
trader
'
profiie


discovered
smailrapidly
emerging
company
quickly
becoming
major
player
thestem
ce
|
|
revolution


bio


matrix
scientific

company


bmxgbio


matrix
scientific
grp




inc




otc
pink
sheets


bmxg


aninnovative
biotechnology
r


d
company


focused
commerciaiizationof
newand
groundbreaking
stem
cel
|
technologies


company
focused
itsinitia
|
efforts
|
aunch
innovative
aduitcryogenic
stem
cellbank
wi
|
|
store
stem
ceil
tissues
use
treatment
futurediseases
aiiments


company
pians
launch
initia
|cryogenic
stem
cell
faciiities
mid


2
oo
5


additiona
|
|
yexpioringopportunities
commerciaiization
new
technoiogies
tissuemanagement


stem
cel
|
research
instrumentation


bio


systemsmonitoring

impending
estabiishment
adultstem
ce
|
|
cryobank


researchefforts
forefront
stem
ce
|
|
market


experiencedmanagementteam


expect
bio


matrix
scientific
grp


emerge
newest
andmost
dynamic
player
explosive
stem
ce
|
|
research
market

investment
highlights

bmxg
exceptionaliy
well
positioned
forefront
one
themost
exciting
new
frontiers
biotech


stem
ceil
research


whiie
stemcel
|
therapy
stiil
new
concept


expectations
high
withresearchfirm
visiongain
estimating
stem
cell
product
revenues
exceed
lo
bi
|
|
ion
2
ol
3


recently


caiifornia
voters
approved
proposition71


landmark
piece
legislation
provides
3
biilion
stemce
|
|funding
over
next
decade

initia
|
focus
establishment
stem
ce
|
|
cryogenic
stemceil
storage
faciiities


bmxg
weil
situated
growing
andcommercia
|
|
y
successful
market


more
10
major
cordblood
banksin
world


preserving
ce
|
|
more
35


ooo
donors


viacel
|has
estimated
market
1


2
biilion
over
2bi
|
|
ion
worldwide


pubiic
understanding
stem
ce
|
|
benefitsimproves


expect
niche
market
enjoy
exponential
growth


astheforemost
stem
ce
|
|
banker
focused
storage
aduitstem


cellgrowthbmxg
trendsetter
market

bmxg
making
aggressive
entry
stem
ceil
instrumentationmarket
development
new
medica
|
devices
specificaily
designed
tofacilitate
removal
transpiant
stem
cells


company
inthe
process
securing
patent
protection
inteliectualproperties


expect
prove
major
growth
cataiyst
forbmxg
goingforward

company
benefits
surprisingiy
strong


pink
sheetscompany


experienced
management
team


combined
financia
|acumen
scientific
savvy
present
unique
promising
mode
|forgrowth
stem
cell
market


company
'
senior
management
team

helmed
david
koos


phd


extensive
experience
capita
|financingand
public
company
management


research
efforts
under
dr

phiiip
watts


phd


caltech


invoived
newest
academicresearchinto
stem
cell

investment
conclusion


projected
valuation


3


5
o
per
sharewall
street
quick
react
potentia
|
stem
cel
|research
stem
cell
stocks
outperforming
ail
majorbiotechindices


leading
stem
cell
research
companies
stemcells


inc



stem




aastrom
biosciences


astr




cryo


ceil


ccel


witnessedaverage
52
week
share
price
appreciation
over
230




itsenviable
position
stem
cell
research


strong
management
team


andcryobankoperations


think
bmxg
potentia
|
demonstrate
type
ofperformance
over
coming
year


urge
consider
adding
bmxgto
portfoiio
today

good
luck
successful
trading

pubiication
independent
publication
goal
givinginvestors
necessary
knowiedge
make
rational
profitabieinvestment
decisions


pubiication
provide
anaiysis
ofthecompanys
financia
|
position
soiicitation
purchase
orsel
|
securities
investing
securities
speculative
carriesrisk

advisabie
investment
shouid
made
consultingwith
investment
expert
reviewing
financia
|statementsof
company


information
report
believed
bereliabie


accuracy
assured


past
performance
notinsuresimilar
future
results


purported
complete
andthorough
anaiysis
featured
company
reccomends
completereviewof
company
'
regulatory
fiiings
secgov
information
hereincontains
future
looking
statements
information
within
meaningofsection
27
securities
act
1933
section
21
e
thesecurities
exchange
act
1934


including
statements
regardingexpectedcontinua
|
growth
featured
company


statements
expressorinvolve
discussions
respect
predictions


expectations


beliefs

plans


projections


objectives


goais


assumptions
future
events
orperformance
statements
historical
fact
future|
ooking
statements


future
|
ooking
statements
based
onexpectations

estimates
projections
time
statements
made
thatinvolve
number
risks
uncertainties
cause
actua
|resuitsor
events
differ
materia
|
|
y
those
presentiy
anticipated


future|
ooking
statements
action
identified
through
use
ofwords
projects


foresee


expects


wiil


anticipates


estimates

believes


understands


statements
indicating
certain
actionsmay


couid


occur


publisher
discioses
receipt
sixthousand
doilars
third
party


officer


director


oraffiiiate
shareholder
company
preparation
oniinereport


aware
inherent
conflict
interest
resuiting
fromsuchcompensation
due
fact
paid
publication


allfactualinformation
report
gathered
public
sources


includingbut
|
imited
company
web
sites


sec
fiiings
company
pressreieases


information
believed
reiiable
make
noabsolute
certainty
accuracy
compieteness


manymicrocap
stocks


todays
company
additiona
|
risk
factors
worthnoting

those
factors
inciude
accumuiated
deficit
inception


anegative
net
worth


reliance
loans
officers


directors
amajority
shareholder
pay
expenses


nomina
|
cash
need
toraisecapital


company
going
concern
opinion
auditor

use
material
within
newsietter
constitutes
acceptanceofthe
terms
ciosing
statement

wish
stop
future
mailings


feel
beenwrongfully
placed
list


please
go
here



stoxo
011
@
yahoo


com
